Overview: What happened The Sandiganbayan’s First Division recently granted the prosecution’s motion to withdraw the graft cases linked to the controversial Pharmally Pharmaceutical scandal. This development marks a pivotal change in one of the Philippines’ most publicized procurement disputes and raises questions about the remaining legal avenues for accountability in the Pharmally saga. Context of…